DL-BUTHIONINE-(S,R)-SULFOXIMINE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
(R)-(-)-MEPHENYTOIN
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
INDOMETHACIN CRYSTALLINE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, MULTI-DRUG RESISTANCE, DRUG EFFLUX PUMPS
TERFENADINE ALCOHOL METABOLITE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
DIGITOXIN CRYSTALLINE
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, MULTI-DRUG RESISTANCE, DRUG EFFLUX PUMPS
4'-HYDROXYWARFARIN
CELL SIGNALLING, SMALL MOLECULES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, SUBSTRATES
MDR1 MEMBRANE PREPARATION
MDR1 human, membrane preparation, for ATPase, Sf9 cells
UDP-GLYCOSYLTRANSFERASE 1A7 ISOZYME
CELL SIGNALLING, PROTEINS & PEPTIDES, MULTI-DRUG RESISTANCE & DRUG METABOLISM, DRUG AND XENOBIOTIC METABOLISM, CONJUGATE PATHWAY
MORPHINE-3,6-DIGLUCURONIDE TETRAHYDRATE, DEA SCHEDULE II
Morphine-3,6-diglucuronide tetrahydrate, To be determined